Provides automated microbial detection solutions for pharmaceutical manufacturing and quality control.
Rapid Micro Biosystems, Inc. is a leading life sciences technology company specializing in advanced products for detecting microbial contamination across pharmaceutical, medical device, and personal care product manufacturing sectors globally. At the core of its offerings is the Growth Direct platform, a comprehensive solution comprising the Growth Direct system, proprietary consumables, lab information management system connectivity software, and extensive customer support and validation services. This platform revolutionizes microbial quality control (MQC) testing by automating and modernizing workflows essential for biologics, vaccines, cell and gene therapies, and sterile injectables.
The company's solutions cater to critical applications such as environmental monitoring, water testing, bioburden assessment, and sterility release testing. Beyond product delivery, Rapid Micro Biosystems excels in providing comprehensive services including installation, verification, technical training, and ongoing support. These offerings ensure seamless integration and reliable operation of its innovative technologies within diverse manufacturing environments.
Founded in 2006 and headquartered in Lowell, Massachusetts, Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. before rebranding in January 2007. With a steadfast commitment to advancing microbial detection technologies, the company continues to play a pivotal role in enhancing manufacturing efficiencies and product safety across global life sciences industries.